Home › Core › ISCC-IDs › 28CrXcA8WNrtB

View ISCC-ID

Core Data

28CrXcA8WNrtB
ISCC-ID - digital asset identifier
CCeH6U4mTEddD-CThWAnNu7MU3b-CDLLfZAUTuD4E-CRfaDv2nYDSwW
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

synergistic cytotoxicity of gemcitabine clofarabine and edelfosine in lymphoma cell lines

Ledger Reference

coblo
Source Ledger/Blockchain
604779
N-th ISCC Decleration on source ledger
4b485e1ada8ffba0de39f9266622afc5f24c9dcff1172a8ef9eadc4d0d044c3c
Hash of block that includes the ISCC-DECLARATION
a47d1575a65f0eca1173761a0a220672af3b41136835f81d642e5d8e2b97648f
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "B C Valdez", "@type": "Person"}, {"name": "A R Zander", "@type": "Person"}, {"name": "G Song", "@type": "Person"}, {"name": "D Murray", "@type": "Person"}, {"name": "Y Nieto", "@type": "Person"}, {"name": "Y Li", "@type": "Person"}, {"name": "R E Champlin", "@type": "Person"}, {"name": "B S Andersson", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc3913938?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1038/bcj.2013.69", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCeH6U4mTEddD-CThWAnNu7MU3b-CDLLfZAUTuD4E-CRfaDv2nYDSwW", "propertyID": "ISCC"}], "datePublished": "2014-01-10"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close